Here you will find the latest ESG and investor relations news, studies and press releases from cometis AG and our partner PRGN – Public Relations Global Network. With the capital market panel and the investor relations panel, cometis has been conducting studies on current market events in the areas of capital markets, ESG and investor relations for several years. To this end, cometis surveys experts from the respective departments several times a year on current topics. In this context, cometis evaluates the topics and the concept and is also responsible for conducting the study.
Here, you can go directly to the respective years of Investor Relations News:
July 29, 2019 | Dermapharm Holding SE: Dr. Jürgen Ott named new CMO
Grünwald, July 29, 2019 – The Supervisory Board of Dermapharm Holding SE (“Dermapharm”) has announced a change in the composition of the Management Board. The current Chief Marketing Officer Stefan Grieving will be leaving the company for health reasons on July 31, 2019. Dr. Jürgen Ott to succeed him as of October 1, 2019.
04 July 2019 | DEAG: Convertible bond 2016/2019 fully converted into shares
Berlin, 4 July 2019 – DEAG Deutsche Entertainment Aktiengesellschaft (DEAG), Berlin, (ISIN: DE000A0Z23G6 | Ticker Symbol: ERMK), has announced that all convertible bonds (ISIN DE000A2AAX86) with a total par value of EUR 4,300,000.00 have been converted into new no-par value ordinary bearer shares of DEAG (the “shares”). This equates to 1,228,553 shares on the basis of the conversion ratio defined in the bond terms. In today's mandatory conversion, an additional 571,420 shares were generated, resulting in a new total of 19,625,976 shares.